Sherine Elsawa

Dr. Sherine Elsawa is at the forefront of discovery in the field of cancer research, serving as an Associate Professor in Molecular, Cellular, and Biomedical Sciences at the University of New Hampshire. Her pioneering work delves into the intricate dynamics of the tumor microenvironment, particularly its role in the development and progression of lymphoma. Dr. Elsawa's research is centered on understanding the molecular mechanisms that govern the interactions between malignant cells and their surrounding microenvironment. A significant focus of Dr. Elsawa's research is the bone marrow microenvironment, especially in the context of Waldenström macroglobulinemia, a rare type of non-Hodgkin lymphoma. Her team is dedicated to unraveling the complex crosstalk that occurs between tumor cells and their microenvironment, aiming to identify novel therapeutic targets that could disrupt these interactions and offer new avenues for cancer treatment. Dr. Elsawa's work is characterized by its innovative approach to cancer therapy, seeking to translate fundamental scientific discoveries into practical treatments. By targeting the supportive environment that tumors rely on, her research holds the potential to improve therapeutic outcomes for patients with lymphoma and other cancers. In addition to her research endeavors, Dr. Elsawa is committed to mentoring the next generation of scientists. She actively engages with students and colleagues, fostering a collaborative and dynamic research environment. Her dedication to both research and education underscores her role as a leader in the scientific community. Dr. Elsawa's contributions to the field have been recognized through various awards and publications, reflecting her impact on advancing our understanding of cancer biology. Her work continues to inspire and drive progress in the quest for more effective cancer therapies.